Jamie A. Donadio
2018
In 2018, Jamie A. Donadio earned a total compensation of $1.6M as Senior Vice President and Chief Financial Officer at Mirati Therapeutics, a 150% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $217,800 |
|---|---|
| Option Awards | $1,040,832 |
| Salary | $363,000 |
| Other | $2,500 |
| Total | $1,624,132 |
Donadio received $1M in option awards, accounting for 64% of the total pay in 2018.
Donadio also received $217.8K in non-equity incentive plan, $363K in salary and $2.5K in other compensation.
Rankings
In 2018, Jamie A. Donadio's compensation ranked 6,785th out of 14,244 executives tracked by ExecPay. In other words, Donadio earned more than 52.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,785 out of 14,244 | 52nd |
Division Manufacturing | 2,594 out of 5,765 | 55th |
Major group Chemicals And Allied Products | 974 out of 2,128 | 54th |
Industry group Drugs | 817 out of 1,817 | 55th |
Industry Pharmaceutical Preparations | 637 out of 1,391 | 54th |
Source: SEC filing on April 19, 2019.
Donadio's colleagues
We found four more compensation records of executives who worked with Jamie A. Donadio at Mirati Therapeutics in 2018.
2018
Charles Baum
Mirati Therapeutics
Chief Executive Officer
2018
James Christensen
Mirati Therapeutics
Chief Scientific Officer
2018
Chris LeMasters
Mirati Therapeutics
Executive Vice President and Chief Business Officer
2018
Isan Chen
Mirati Therapeutics